Key details
Collaborators
Jiangsu HengRui Medicine Co., Ltd.
Enrollment target
~38 participants
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated January 2025